Holen Sie sich die Stockscreener-App
85.50
7.74%
6.14
Handel nachbörslich:
85.71
0.21
+0.25%
Schlusskurs vom Vortag:
$79.36
Offen:
$79.51
24-Stunden-Volumen:
347.61K
Relative Volume:
1.25
Marktkapitalisierung:
$3.93B
Einnahmen:
$305.11M
Nettoeinkommen (Verlust:
$-196.00K
KGV:
-13,153.85
EPS:
-0.0065
Netto-Cashflow:
-
1W Leistung:
+21.95%
1M Leistung:
+16.31%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$79.51
$85.76
1-Wochen-Bereich:
$71.13
$85.76
52-Wochen-Spanne:
$61.96
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Firmenname
Billiontoone Inc
Sektor
Branche
Telefon
650-460-2551
Adresse
1035 O'BRIEN DRIVE, MENLO PARK
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
85.50 | 3.65B | 305.11M | -196.00K | 0 | -0.0065 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.84 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.09 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2025-12-01 | Eingeleitet | BTIG Research | Buy |
| 2025-12-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-12-01 | Eingeleitet | Jefferies | Hold |
| 2025-12-01 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Eingeleitet | Stifel | Buy |
| 2025-12-01 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-12-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Billiontoone Inc Aktie (BLLN) Neueste Nachrichten
Why BillionToOne Stock Is Suddenly Surging Higher - TipRanks
BillionToOne, Inc. (BLLN) Options Chain - Yahoo! Finance Canada
BillionToOne appoints Allen Chen as oncology VP By Investing.com - Investing.com Canada
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com
BillionToOne appoints Allen Chen as oncology VP - investing.com
Billiontoone appoints Dr. Allen Chen as vice president of medical affairs and clinical development, oncology - marketscreener.com
Billiontoone Appoints Dr. Allen Chen As Vice President Of Medical Affairs And Clinical Development, Oncology - TradingView
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology - Bitget
BillionToOne puts 20-year cancer leader over Northstar medical strategy - Stock Titan
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $100 - Moomoo
InvestingPro spotted BillionToOne’s 46% drop four months in advance By Investing.com - Investing.com
Why BillionToOne, Inc. Class A Shares Are Sinking - TipRanks
BillionToOne And 2 More Growth Companies With Strong Insider Ownership - Yahoo Finance
BillionToOne Inc (BLLN) Shares Up 3.33% on Mar 25 - gurufocus.com
BillionToOne, Inc.(NasdaqGS: BLLN) added to S&P Global BMI Index - MarketScreener
Piper Sandler reiterates BillionToOne stock rating on NIPT tech By Investing.com - Investing.com Nigeria
Piper Sandler reiterates BillionToOne stock rating on NIPT tech - Investing.com
Billiontoone (BLLN) Stock Trends and Sentiment 2026 $BLLN - MarketBeat
BillionToOne Inc (BLLN) Stock Price Up 3.48% on Mar 16 - gurufocus.com
Billiontoone (BLLN) Stock Forecast and Price Target 2026 $BLLN - MarketBeat
BillionToOne (NASDAQ: BLLN) Shares Climb 8% Amid Strong Momentum in Precision Diagnostics Sector - International Business Times Australia
BTIG lowers BillionToOne stock price target on valuation multiples - Investing.com Nigeria
BillionToOne, Inc.: Fundamental Analysis and Financial Ratings | BLLN | US0901681058 - marketscreener.com
BillionToOne Inc (BLLN) Shares Up 6.14% on Mar 13 - GuruFocus
BillionToOne’s Single-Molecule Next-Generation Sequencing Platform Redefines Molecular Diagnostics for Prenatal and Oncology Care 404148 - Minichart
BillionToOne 10-K: Revenue $305.1M, EPS $0.14 - TradingView
Billiontoone (NASDAQ:BLLN) Hits New 1-Year LowHere's What Happened - MarketBeat
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
BillionToOne Medicare Win Puts North Star Economics In Focus - Yahoo Finance
BillionToOne Market Share Gains Raise Questions On Undervalued BLLN Stock - simplywall.st
BLLN (BillionToOne) PB Ratio : (As of Mar. 07, 2026) - GuruFocus
Wall Street Zen Upgrades Billiontoone (NASDAQ:BLLN) to "Buy" - MarketBeat
BillionToOne (BLLN) Turns Profitable As Q4 EPS And Margins Challenge Bearish Narratives - simplywall.st
BillionToOne: Delivering And Lagging At The Same Time (NASDAQ:BLLN) - Seeking Alpha
Analysts Are Bullish on These Healthcare Stocks: BillionToOne, Inc. Class A (BLLN), Concentra Group Holdings Parent, Inc. (CON) - The Globe and Mail
What Makes BillionToOne (BLLN) an Attractive Bet? - Yahoo Finance
BTIG Maintains Buy on BillionToOne, Inc. (BLLN) March 2026 - Meyka
Billiontoone (NASDAQ:BLLN) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
BillionToOne Q4 2025 Results: Profit & Revenue Surpass ForecastsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Assessing BillionToOne (BLLN) Valuation After Recent Share Price Volatility - simplywall.st
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Nigeria
Wells Fargo & Company Has Lowered Expectations for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat
BTIG lowers BillionToOne stock price target on valuation multiples By Investing.com - Investing.com India
Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat
Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat
BLLN: BTIG Analyst Lowers Price Target Amid Maintained 'Buy' Rat - GuruFocus
BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq
Finanzdaten der Billiontoone Inc-Aktie (BLLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):